Solving manufacturing problems for L-carnitine-L-tartrate to improve the likelihood of successful product scale-up

1. M. Nishimura, T. Tokoro, T. Takatani, N. Sato, M. Nishida, T. Hashimoto, S. Yamazaki, H. Kobayashi and T. Ono, Effects of intravenous l-carnitine on myocardial fatty acid imaging in hemodialysis patients: responders or non-responders to l-carnitine, Springerplus 4 (2015) 353-362; https://doi.org/10.1186/s40064-015-1119-z10.1186/s40064-015-1119-zSearch in Google Scholar

2. P. Mason, Dietary Supplements, 3rd ed., Pharmaceutical Press, London 2007. Search in Google Scholar

3. J. L. Flanagan, P. A. Simmons, J. Vehige, M. D. P. Wilcox and Q. Garett, Role of carnitine in disease, Nutr. Metab. (Lond) 7 (2010) 30; https://doi.org/10.1186/1743-7075-7-3010.1186/1743-7075-7-30Search in Google Scholar

4. A. Hassan, Y. Tsuda, A. Asai, K. Yokohma, K. Nakamura, T. Sujishi, H. Ohama, Y. Tsuchimoto, S. Fukunishi, U. M. Abdelaal, U. A. Arafa, A. T. Hassan, A. M. Kassem and K. Higuchi, Effects of oral L-Carnitine on liver functions after transarterial chemoembolization in intermediate-stage HCC patients, Mediators of Inflammation (2015), Article ID 608216, http://dx.doi.org/10.1155/2015/60821610.1155/2015/608216Search in Google Scholar

5. T. Răşanu, M. Mehedinţi-Hâncu, M. Alexianu, T. Mehedinţi, E. Gheorghe and L. Damian, Carnitine deficiency - case report, Roman. J. Morphol Embryol. 53 (2012) 203-206.Search in Google Scholar

6. C. Ulbricht (Ed.), Natural Standard Medical Conditions Reference - An Integrative Approach, Elsevier- Mosby, St. Louis, MO, 2009.Search in Google Scholar

7. J. Yee, L-Carnitine for anemia in hemodialysis patients: A last resort, Clin. J. Am. Soc. Nephrol. 7 (2012) 1746-1748; https://doi.org/10.2215/CJN.0992091210.2215/CJN.09920912Search in Google Scholar

8. European Pharmacopoeia, E. Council of Europe, Strasbourg 2014.Search in Google Scholar

9. The United States Pharmacopeia, NF30, US Pharmacopeial Convention, Maryland 2012.Search in Google Scholar

10. J. Swarbrick (Ed.), Encyclopedia of Pharmaceutical Technology, 3rd Ed., Informa Healthcare, New York 2007.Search in Google Scholar

11. M. Ciper and R. Bodmeier, Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity, Eur. J. Pharm. Biopharm. 62 (2006) 178-184.10.1016/j.ejpb.2005.08.014Search in Google Scholar

12. I. El-Bagory, N. Barakat, M. A. Ibrahim and F. El-Enazi, Formulation and in vitro evaluation of theophylline matrix tablets prepared by direct compression: Effect of polymer blends, Saudi Pharm. J. 20 (2012) 229-238.10.1016/j.jsps.2011.11.007Search in Google Scholar

13. J. Wanga, H. Wenb and D. Desai, Lubrication in tablet formulations, Eur. J. Pharm. Biopharm. 75 (2010) 1-15.10.1016/j.ejpb.2010.01.007Search in Google Scholar

14. S. Mohan, Compression physics of pharmaceutical powders: a review, Int. J. Pharm. Sci. Res.; http://dx.doi.org/10.13040/IJPSR.0975-8232.3(6).1580-9210.13040/IJPSR.0975-8232.3(6).1580-92Search in Google Scholar

15. R. C. Rowe, P. J. Sheskey, W. G. Cook and M. E. Fenton, Handbook of Pharmaceutical Excipients, 7th ed., Pharmaceutical Press, London 2012.Search in Google Scholar

16. Physicians’ Desk Reference (PDR), 67th Ed. PDR Network 2012-01-01, https://06833842-a-62cb3a1as-sites.googlegroups.com/site/wegvergg/ganbate/Physicians-Desk-Reference-.pdf?attachauth=ANoY7cr9vlzLOqqmfplls_9fycwkg7n4tNBeh_DDkuOFHlNLBOL8VMINpJk4TR_WXev_7EinwRSMMJZ-COja82jGaxZL6lOmx0FfjJQg93w08w7_Dh66_nSllfHShXcoqZVqYXS2lvIZCKE-90T3ohWJgU5Epl0PSiWjkE2sqedXyxB442yjE6L3hyfZYUCFIrCknK6M3O1CPPuME3MMc8JTsmvIJZ2alZTcNZcD5EU4e6EXdKSGk%3D&attredirects=0, access date July 25, 2017.Search in Google Scholar

17. British Pharmacopoeia, Flowability, The Pharmaceutical Press, London 2013.Search in Google Scholar

18. N. R. Jadhav, A. R. Paradkar, N. H. Salunkhe, R. S. Karade and G. G. Mane, Talc: A versatile pharmaceutical excipient, World J. Pharm. Pharmaceut. Sci. 2 (2013) 4639-3660.Search in Google Scholar

19. AEROSIL® and AEROPERL® Colloidal silicon dioxide for pharmaceuticals technical information TI 1281 : https://www.aerosil.com/sites/lists/RE/DocumentsSI/TI-1281-AEROSIL-and-AEROPERLColloidal-Silicon-Dioxide-for-Pharmaceuticals-EN.pdf; access date July 25, 2017.Search in Google Scholar

20. G. Ragnarsson, A. W. Hdlzer and J. Sjogren, The influence of mixing time and colloidal silica on the lubricating properties of magnesium stearate, Int. J. Pharm. 3 (1979) 127-131.10.1016/0378-5173(79)90074-7Search in Google Scholar

21. G. Thoorens, F. Krier, B. Leclercq, B. Carlin and B. Evrard, Microcrystalline cellulose, a direct compression binder in a quality by design environment - A review, Int. J. Pharm. 473 (2014) 64-72.10.1016/j.ijpharm.2014.06.05524993785Search in Google Scholar

22. M. Jivraj, L. G. Martini and C. M. Thomson, An overview of the different excipients useful for the direct compression of tablets, Pharmaceut. Sci. Technol. Today 3 (2000) 58-63.10.1016/S1461-5347(99)00237-0Search in Google Scholar

23. L. Jinjiang and W. Yongmei, Review: Lubricants in pharmaceutical solid dosage forms, Lubricants 2 (2014) 21-43.Search in Google Scholar